Indeed, MFeed+ allows a better use of the feed thanks to a higher activity of enzymes in the intestine. This leads to better production performance, but also to a better digestive well-being.
Within a global approach, MFeed+ contributes to limit the use of antibiotics. Indeed, with a better use of the feed, less undigested feed compounds (“waste”) reach the large intestine, thus contributing to the good balance of the intestinal microflora.
MFeed+ is destined to all monogastric animals, meaning swine, poultry and aqua species.
MFeed+ has been tested at INRA Rennes, and in collaboration with other external partners like ANSES and CTPA in Ploufragan, or international research centers, as far as in Thailand. The studies conducted with all these scientific partners allowed us to run in vivo trials that were necessary to the development of MFeed+, whether it was on-farm trials or studies involving specific experimental facilities (like the digestibility cages at INRA).
The development of MFeed+ is the fruit of two years of hard work, involving all R&D resources in Olmix Group. The product benefits from all improvements achieved with ULVANS program, whether it concerns our knowledge on algae, their cracking, their association with clays; or the possibility to scale up our processes and the new industrial processes that are applicable.
*France, 2014
Local regulations should be consulted concerning the status of this product in the country of destination. All information only for export outside Europe.